title: Tetanus IgG antibody levels in children aged 12 to 47 months in Turkey.
abstract: Tetanus is a serious disease with high mortality, which is very difficult to treat but can be prevented easily by vaccination. The number of tetanus cases reported in Turkey was 42 in 1996 and 51 in 1997. This study was carried out on children aged 12 to 47 months who have vaccination cards in the No. l Health Centre in Batikent district in Ankara, Turkey. Forty-one of the children had received 3 doses (Group 1) of tetanus vaccine, and 47 of them had received 4 doses of the vaccine (Group 2). Anti-toxoid IgG antibody in blood sera was quantified by using the enzyme-linked immunosorbent assay technique. In Group 1, antibody levels more than 0.01 IU/mL were found in 47%, 43%, and 45% of blood sera of children aged 12 to 23 months, 24 to 35 months, and 36 to 47 months, respectively. These rates in Group 2 were found to be 91%, 88%, and 60%, respectively. The protective antibody response (>1 IU/mL) was found to be higher for children in Group 2 than in Group 1, but both rates declined with age. Checking immunization status periodically and giving vaccine doses as required are essential to increase the antibody response. Further, it is a must in developing countries where vaccination efforts are hindered by cold-chain problems, underoptimum application practice, and high prevalence of concomitant infections.
authors: Kirikkale University Medical School, Public Health Department, Ankara, Turkey.
authors: R C
authors: RC
authors: Yildirim
authors: N
authors: N
authors: Yilmaz
authors: U
authors: U
authors: Yildirim
authors: F N
authors: FN
authors: Aksakal
mesh_terms: D017677:Age Distribution; D000907:Antibodies, Bacterial / Q000097:blood*; D002675:Child, Preschool; D003017:Clostridium tetani / Q000276:immunology*; D003906:Developing Countries; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006801:Humans; D007115:Immunization Schedule; D007074:Immunoglobulin G / Q000097:blood*; D007223:Infant; D008297:Male; D020380:Needs Assessment; D011159:Population Surveillance; D016036:Seroepidemiologic Studies; D011795:Surveys and Questionnaires; D013742:Tetanus / Q000453:epidemiology / Q000517:prevention & control*; D013745:Tetanus Toxoid / Q000276:immunology*; D014421:Turkey / Q000453:epidemiology; D014504:Urban Health / Q000706:statistics & numerical data; D014611:Vaccination / Q000379:methods / Q000592:standards / Q000706:statistics & numerical data
chemical_list: D000907:Antibodies, Bacterial; D007074:Immunoglobulin G; D013745:Tetanus Toxoid